Anthony O Caggiano

This inventor holds 36 USPTO granted patents and 23 published patent applications, plus 11 CIPO patents and 25 EPO patents, primarily in Cardiac and CNS Treatments. Top assignee: Acorda Therapeutics, Inc.. Active years: 2008-2022.

USPTO Granted Patents = 36 (Patent Applications = 23)

% Patents Active = 44.4

CIPO Patents = 11 (Patent Applications = 6)

EPO Patents = 25 (Patent Applications = 27)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Hawthorne, NY (US) (2014)
Larchmont, NY (US) (2008 - 2022)

Company Filing History:

36 out of 90

Acorda Therapeutics, Inc.

patents

Years Active: 2008-2022

Loading Chart...

Areas of Expertise:

Neuregulin

Chondroitinase ABCI Mutants

Cardiac Damage Detection

Glial Growth Factor

CNS Neurological Injury

Extravasation Reduction

Therapeutic Dosing

Proteoglycan Degrading Mutants

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11235031 - Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure (2022-02-01),

2. 11141467 - Methods of reducing extravasation of inflammatory cells (2021-10-12),

3. 11071770 - Methods for detecting cardiac damage (2021-07-27),

4. 10675331 - Method for achieving desired glial growth factor 2 plasma levels (2020-06-09),

5. 10668131 - Compositions and methods for treatment during non-acute periods following CNS neurological injury (2020-06-02),

6. 10323240 - Compositions and methods of using chondroitinase ABCI mutants (2019-06-18),

7. 10258667 - Methods for detecting cardiac damage (2019-04-16),

8. 9987340 - Compositions and methods of using chondroitinase ABCI mutants (2018-06-05),

9. 9956266 - Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure (2018-05-01),

10. 9839679 - Methods of reducing extravasation of inflammatory cells (2017-12-12),

11. 9834764 - Compositions and methods of using chondroitinase ABCI mutants (2017-12-05),

12. 9757429 - Methods for detecting cardiac damage (2017-09-12),

13. 9744215 - Method for achieving desired glial growth factor 2 plasma levels (2017-08-29),

14. 9528102 - Proteoglycan degrading mutants for treatment of CNS (2016-12-27),

15. 9498515 - Compositions and methods for treatment during non-acute periods following CNS neurological injury (2016-11-22),

Title: The Innovative Mind of Anthony O Caggiano

Introduction: Anthony O Caggiano, a talented inventor hailing from Larchmont, NY, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Anthony O Caggiano holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing solar panel efficiency.

Career Highlights: With a career spanning over two decades, Anthony O Caggiano has worked for renowned tech companies, leading research institutions, and universities. His expertise in developing cutting-edge solutions has earned him a reputation as a visionary in the industry.

Collaborations: Throughout his career, Anthony O Caggiano has collaborated with top engineers, scientists, and researchers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has resulted in the successful implementation of several groundbreaking projects.

Conclusion: Anthony O Caggiano's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating technologies that have the potential to shape the future. His remarkable contributions to the field of invention make him a true pioneer in his field.